You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CNTO 148

Showing 1 - 25 of 164
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Biopsy, Biospecimen Collection)

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 20, 2023

Arthritis, Psoriatic Trial in Worldwide (Guselkumab, Golimumab, Placebo)

Recruiting
  • Arthritis, Psoriatic
  • Phoenix, Arizona
  • +96 more
Jan 17, 2023

Diabetes, Type 1 Trial in San Diego (Golimumab)

Available
  • Diabetes Mellitus, Type 1
  • San Diego, California
    Rady Children's Hospital
Jul 28, 2022

Adult Moderate-to-Severe Ulcerative Colitis

Active, not recruiting
  • Ulcerative Colitis
    • Murrieta, California
    • +62 more
    Jan 17, 2023

    Pre-Symptomatic Type 1 Diabetes Trial in Finland, Sweden, United States (Golimumab, Placebo)

    Completed
    • Pre-Symptomatic Type 1 Diabetes
    • Aurora, Colorado
    • +7 more
    Sep 9, 2021

    Arthritis, Juvenile Trial in Worldwide (Golimumab, Methotrexate)

    Active, not recruiting
    Has Results
    • Arthritis, Juvenile
    • San Diego, California
    • +37 more
    Jan 17, 2023

    Colitis, Ulcerative Trial in Worldwide (Golimumab, Infliximab)

    Recruiting
    • Colitis, Ulcerative
    • San Francisco, California
    • +64 more
    Aug 17, 2022

    Psoriasis Trial in Worldwide (Guselkumab 100 mg, Placebo for guselkumab, Adalimumab)

    Completed
    Has Results
    • Psoriasis
    • Guselkumab 100 mg
    • +3 more
    • Los Angeles, California
    • +97 more
    Jul 22, 2021

    Primary Progressive Multiple Sclerosis Trial in Israel, Moldova, Republic of (GA Depot 40mg once monthly, GA Depot 25mg once

    Recruiting
    • Primary Progressive Multiple Sclerosis
    • GA Depot 40mg once monthly
    • GA Depot 25mg once monthly
    • Haifa, Israel
    • +6 more
    Oct 30, 2022

    Diabetic Ketoacidosis Trial in St Leonards, Redcliffe (Plasma-Lyte 148, 0.9% sodium chloride)

    Not yet recruiting
    • Diabetic Ketoacidosis
    • Plasma-Lyte 148
    • 0.9% sodium chloride
    • St Leonards, New South Wales, Australia
    • +1 more
    Feb 28, 2023

    Alcohol Abuse, Alcohol Drinking, Alcohol Use Disorder Trial in London (DrinksRation, BeAlcoholSmart)

    Not yet recruiting
    • Alcohol Abuse
    • +2 more
    • DrinksRation
    • BeAlcoholSmart
    • London, United Kingdom
      King's Centre for Military Health Research
    Jul 24, 2023

    HIV Trial in Worldwide (DTG + 3TC, TAF based regimen (TBR))

    Completed
    Has Results
    • HIV Infections
    • DTG + 3TC
    • TAF based regimen (TBR)
    • Phoenix, Arizona
    • +132 more
    Jun 27, 2022

    Pregnancy Related, Anxiety Trial in Amasya (The Childbirth and Parenthood Preparation Education)

    Not yet recruiting
    • Pregnancy Related
    • Anxiety
    • The Childbirth and Parenthood Preparation Education
    • Amasya, Turkey
      Amasya University
    Aug 7, 2023

    Distal Femur Fracture, Periprosthetic Fracture Around Prosthetic Joint Implant Knee, Knee Fracture Trial (Distal Femur

    Not yet recruiting
    • Distal Femur Fracture
    • +2 more
    • Distal Femur Replacement
    • Surgical fixation
    • (no location specified)
    Mar 28, 2023

    HIV Trial in Worldwide (DTG 50 mg, RPV 25 mg, CAR)

    Active, not recruiting
    Has Results
    • HIV Infections
    • DTG 50 mg
    • +2 more
    • Long Beach, California
    • +64 more
    Dec 3, 2021

    HIV Trial in Worldwide (DTG 50 mg, RPV 25 mg, CAR)

    Active, not recruiting
    Has Results
    • HIV Infections
    • DTG 50 mg
    • +2 more
    • Bakersfield, California
    • +61 more
    Dec 3, 2021

    Immune System Disorder Trial in Chang Chun (HLX03, adalimumab)

    Completed
    • Immune System Disorder
    • Chang Chun, Jilin, China
      the 1st affiliated hospital of Jilin University
    May 4, 2022

    Pregnancy Related Trial in Kahramanmaras (Motivational Interview)

    Completed
    • Pregnancy Related
    • Motivational Interview
    • Kahramanmaraş, Onikişubat, Turkey
      Department of Midwifery, Faculty of Health Sciences Sutcuimam Un
    Aug 23, 2023

    Psoriasis Trial in Worldwide (Guselkumab 100 mg, Placebo for guselkumab, Adalimumab)

    Completed
    Has Results
    • Psoriasis
    • Guselkumab 100 mg
    • +3 more
    • Birmingham, Alabama
    • +95 more
    Jun 29, 2021

    Hypovolemia Trial in Australia, New Zealand (Plasma-Lyte 148®, 0.9% sodium chloride)

    Completed
    • Hypovolemia
    • Plasma-Lyte 148®
    • 0.9% sodium chloride
    • Blacktown, New South Wales, Australia
    • +50 more
    Oct 20, 2021

    Obese, Endotracheal Tube, Laryngeal Mask Airway Trial in Dallas, Houston (Second-Generation Laryngeal Mask Airway)

    Recruiting
    • Obese
    • +2 more
    • Second-Generation Laryngeal Mask Airway
    • Dallas, Texas
    • +1 more
    Feb 11, 2022

    End Stage Kidney Disease, Delayed Graft Function, Kidney Transplant; Complications Trial in Australia, New Zealand (Plasma-Lyte

    Completed
    • End Stage Kidney Disease
    • +2 more
    • Plasma-Lyte 148 (approx. pH 7.4) IV Infusion
    • 0.9% SODIUM CHLORIDE 9g/L injection BP
    • Randwick, New South Wales, Australia
    • +17 more
    Dec 12, 2022

    Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (Dolutegravir (DTG), Lamivudine (3TC), Tenofovir disoproxil

    Active, not recruiting
    Has Results
    • Infection, Human Immunodeficiency Virus
    • HIV Infections
    • Dolutegravir (DTG)
    • +2 more
    • Phoenix, Arizona
    • +89 more
    Jun 27, 2022

    Diabetes, Type 1, Closed-Loop Trial in France (Open-loop condition, Closed-loop condition)

    Terminated
    • Diabetes Mellitus, Type 1
    • Closed-Loop
    • Open-loop condition
    • Closed-loop condition
    • Caen, France
    • +8 more
    Apr 6, 2021

    Safety and Tolerability Trial in Baltimore (YJ001 for Spray Use, Placebo of YJ001 for Spray Use)

    Not yet recruiting
    • Safety and Tolerability
    • YJ001 for Spray Use
    • Placebo of YJ001 for Spray Use
    • Baltimore, Maryland
      Pharmaron CPC, Inc.
    Jul 5, 2022